echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > NEJM case: Zollinger–Ellison syndrome

    NEJM case: Zollinger–Ellison syndrome

    • Last Update: 2022-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    Zollinger–Ellison syndrome, also known as Zollinger–Ellison syndrome, is a chronic refractory ulcer
    of the upper gastrointestinal tract caused by non-β islet cell tumor or antral G-cell proliferation that occurs in the pancreas.
    The peptic ulcer caused by the former is called Zhuolig syndrome type II, while the peptic ulcer caused by the latter is called type
    In 1955, Zollinger and Ellison first reported two such cases in 1956, when Eiseman and Maynard proposed that the syndrome be called Zollinger syndrome

    Later, with the deepening of the understanding of this disease, many other names such as gastrinoma, pancreatic ulcer, primary gastrin hypertrophosis pancreatic non-β cell tumor, etc
    have appeared.
    Gastric juice stimulating tumor secretes a large amount of gastric juice stimulating gastric juice hormone, constantly stimulating gastric parietal cells to secrete a large amount of gastric acid, and finally causing gastroduodenal mucosal damage, erosion and ulceration, because it is a tumor, this process is always going on, so the treatment of general peptic ulcer drugs is difficult to get good effect

    For the small intestine, gastric juice stimulating hormone can inhibit its absorption of water and electrolytes and promote the increase of small intestinal peristalsis, so patients with gastric juice protoma may have watery diarrhea, and gastric juice can also promote the increase of pancreatic exocrine, and also increase the secretion of
    bile duodenal fluid.
    These have strengthened the factors of diarrhea, but the most important is the continuous large-scale secretion of tumors, resulting in serious results
    such as refractory ulcers with bleeding and perforation.

    One case
    was reported in the latest issue of the New England magazine.

    A 75-year-old man presents to the emergency department with epigastric pain, watery diarrhoea, and weight loss for 6 months
    Physical examination may reveal epigastric tenderness
    Esophagogastroduodenoscopy shows severe esophagitis (figure A), antral erosions, and duodenal ulcer (figure B).

    Gastric pH below 2 and fasting serum gastrin levels above 1000 pg/mL (reference range, 13-115) establish the diagnosis of Zollinger-Ellison syndrome, a syndrome
    of gastric acid hypersecretion caused by gastrinoma.
    With initiation of proton-pump inhibitor therapy, patients experience less
    frequent episodes of abdominal pain and diarrhea.
    A computed tomography scan with positron emission tomography found a tumor
    in the fourth part of the duodenum.
    Procedures with curative intent were performed, including segmental duodenectomy and lymphadenectomy (figure C; Arrows indicate tumors).

    Histopathologic analysis shows a well-differentiated neuroendocrine tumour within the lymph node, and immunohistochemical staining is positive for gastrin (figure D).

    At 3 months postoperatively, fasting serum gastrin levels were 44 pg/mL, and esophagogastroduodenoscopy was normal
    The dose of the proton-pump inhibitor was gradually reduced, and the patient's symptoms did not recur
    after discontinuation of the proton-pump inhibitor.

    Original source:

    The Zollinger–Ellison Syndrome.
    N Engl J Med 2022; 387:1699 DOI: 10.

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.